EcoDrugPlus

Tubulin Beta-2a Chain

Ensembl ID : ENSMAUG00000018540
Gene Symbol: LOC101833816
4 Cross references
183 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMAUG00000022241
Gene Symbol: TP53
2 Cross references
253 Possible Orthologues:

Type-1a Angiotensin Ii Receptor

Ensembl ID : ENSMAUG00000017279
Gene Symbol: LOC101840244
4 Cross references
195 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMAUG00000001154
Gene Symbol: TYR
4 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSMAUG00000018721
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSMAUG00000017865
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSMAUG00000000809
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSMAUG00000006284
Gene Symbol: UTRN
2 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSMAUG00000007292
Gene Symbol: VEGFA
2 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSMAUG00000015419
Gene Symbol: VDR
4 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSMAUG00000006018
Gene Symbol: LOC101840628
3 Cross references
189 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSMAUG00000016555
Gene Symbol: XDH
4 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).